Targeted Oncology6d
FDA Accepts BLA for RP1 With Nivolumab in Advanced Melanoma
The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the ...
Hosted on MSN17d
Qiagen scoops FDA clearance for gastrointestinal panel
Throughout last year, Qiagen was granted FDA clearance for four QIAstat-Dx ... QIAstat-Dx system operations in Esplugues de Llobregat, Barcelona, Spain. Due to open early next year, the new ...